デフォルト表紙
市場調査レポート
商品コード
1619061

マイクロバイオームシーケンスサービス市場規模、シェア、成長分析、サービス別、技術別、地域別 - 産業予測、2024~2031年

Microbiome Sequencing Services Market Size, Share, Growth Analysis, By Service (Sample Preparation, Sequencing and Library Preparation), By Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL)), By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
マイクロバイオームシーケンスサービス市場規模、シェア、成長分析、サービス別、技術別、地域別 - 産業予測、2024~2031年
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

マイクロバイオームシーケンスサービスの世界市場規模は、2022年に13億7,000万米ドルと評価され、2023年の15億2,000万米ドルから2031年には34億8,000万米ドルに成長し、予測期間中(2024~2031年)のCAGRは10.9%で成長する見通しです。

マイクロバイオームシーケンスサービス市場は、遺伝子技術の進歩、健康におけるヒトマイクロバイオームの役割に対する認識の高まり、個別化医療に対する需要の高まりによって急速な成長を遂げています。微生物コミュニティと全体的な健康との関係を強調する調査は、自身のマイクロバイオームを理解することへの消費者の関心を煽り、シーケンスサービスのニーズを高めています。このようなサービスは、様々な疾患に対するマイクロバイオームベースの薬剤の出現により、治療において不可欠なものとなりつつあります。トランスクリプトミクス、メタボロミクス、ゲノムデータを組み合わせたマルチオミクスアプローチの人気は研究成果を高め、細菌とヒトの健康との複雑なつながりを強化しています。さらに、増え続ける微生物ゲノムデータの処理にはバイオインフォマティクスの進歩が必要であり、正確な診断への道を開き、環境研究や農業への応用を強化します。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術の進歩
  • 規制情勢
  • 特許分析
  • ケーススタディ

マイクロバイオームシーケンスサービス市場規模:サービス別およびCAGR(2024~2031年)

  • 市場概要
  • サンプル調製
  • シーケンシングとライブラリの準備
  • データ分析

マイクロバイオームシーケンスサービス市場規模:技術別およびCAGR(2024~2031年)

  • 市場概要
  • 合成によるシーケンシング
  • 連結によるシーケンシング
  • ピロシーケンシング
  • サンガー法シーケンシング
  • その他

マイクロバイオームシーケンスサービス市場規模:用途別およびCAGR(2024~2031年)

  • 市場概要
  • ショットガンシーケンシング
  • ターゲット遺伝子シーケンシング
  • RNAシーケンシング
  • 全ゲノムシーケンシング
  • その他

マイクロバイオームシーケンスサービス市場規模:エンドユーザー別およびCAGR(2024~2031年)

  • 市場概要
  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • 病院と診療所
  • その他

マイクロバイオームシーケンスサービス市場規模およびCAGR(2024~2031年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021~2023年)

主要企業プロファイル

  • Charles River Laboratories
  • Eurofins Scientific
  • BGI
  • Microbiome Insights Inc.
  • MR DNA
  • Baseclear BV
  • Clinical Microbiomics AS
  • Zymo Research
  • Rancho Biosciences
  • Metabiomics
  • CosmosID
  • ZIFO
  • Shanghai Realbio Technology(RBT)Co., Ltd.
  • Second Genome

結論と推奨事項

目次
Product Code: SQMIG35J2091

Global Microbiome Sequencing Services Market size was valued at USD 1.37 billion in 2022 and is poised to grow from USD 1.52 billion in 2023 to USD 3.48 billion by 2031, growing at a CAGR of 10.9% during the forecast period (2024-2031).

The market for microbiome sequencing services is experiencing rapid growth driven by advancements in genetic technology, increased awareness of the human microbiome's role in health, and a rising demand for personalized medicine. Research highlighting the relationship between microbial communities and overall health fuels consumer interest in understanding their own microbiomes, thus elevating the need for sequencing services. These services are becoming integral in medical treatments, with microbiome-based medications for various diseases emerging. The popularity of multi-omics approaches-combining transcriptomics, metabolomics, and genomic data-enhances research outcomes, reinforcing the intricate connection between bacteria and human health. Additionally, advancements in bioinformatics are needed to process growing microbial genomic data, paving the way for accurate diagnoses and enhancing applications in environmental studies and agriculture.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbiome Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbiome Sequencing Services Market Segmental Analysis

Global Microbiome Sequencing Services Market is segmented by service, technology, application, end user and region. Based on service, the market is segmented into Sample Preparation, Sequencing and Library Preparation, and Data Analysis. Based on technology, the market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing and others. Based on application, the market is segmented into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing and others. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microbiome Sequencing Services Market

The global microbiome sequencing services market is significantly driven by the rising demand for personalized medicine. As healthcare increasingly shifts towards tailored approaches for individuals, microbiome analysis becomes essential in understanding the unique composition of microorganisms within each patient. This targeted analysis aids in the accurate diagnosis and effective management of various health conditions, enhancing treatment outcomes. Consequently, the growing emphasis on personalized healthcare solutions is fueling the expansion of the microbiome sequencing services market, as more healthcare professionals seek to incorporate these advanced analytical techniques into their practices to optimize patient care.

Restraints in the Global Microbiome Sequencing Services Market

A major constraint facing the Global Microbiome Sequencing Services market is the prohibitive cost associated with sequencing. Despite advancements in technology, the expenses related to sequencing equipment, reagents, and data analysis remain substantial. This financial barrier poses challenges for smaller research institutions and clinics, making it difficult for them to access and implement these services. As a result, the high costs hinder widespread adoption and utilization of microbiome sequencing, ultimately stifling the growth prospects of the market and limiting opportunities for innovation and research in the field.

Market Trends of the Global Microbiome Sequencing Services Market

The global microbiome sequencing services market is experiencing a significant trend toward the integration of Artificial Intelligence (AI) and machine learning technologies. This shift enhances the analysis of complex microbiome data, facilitating a deeper understanding of microbial interactions and their implications for health and disease prevention. As AI-driven tools become more prevalent, they enable researchers and healthcare professionals to derive actionable insights from vast amounts of sequencing data, leading to improved therapeutic strategies and personalized medicine approaches. Consequently, the demand for advanced microbiome analysis services is anticipated to surge, reflecting a broader movement towards data-driven solutions in life sciences and healthcare sectors.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies

Global Microbiome Sequencing Services Market Size by Service & CAGR (2024-2031)

  • Market Overview
  • Sample Preparation
  • Sequencing and Library Preparation
  • Data Analysis

Global Microbiome Sequencing Services Market Size by Technology & CAGR (2024-2031)

  • Market Overview
  • Sequencing by Synthesis (SBS)
  • Sequencing by Ligation (SBL)
  • Pyrosequencing
  • Sanger Sequencing
  • Others

Global Microbiome Sequencing Services Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • RNA Sequencing
  • Whole Genome Sequencing
  • Others

Global Microbiome Sequencing Services Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospitals and Clinics
  • Others

Global Microbiome Sequencing Services Market Size & CAGR (2024-2031)

  • North America, (Service, Technology, Application, End User)
    • US
    • Canada
  • Europe, (Service, Technology, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Service, Technology, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Service, Technology, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Service, Technology, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Charles River Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microbiome Insights Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MR DNA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baseclear BV
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clinical Microbiomics AS
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymo Research
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rancho Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metabiomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CosmosID
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZIFO
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai Realbio Technology (RBT) Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Second Genome
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation